Open Access

Finerenone use in CKD and T2D: from clinical trials to the clinic.

Congress Session

About the speakers

Doctor Pam Taub

San Diego (United States of America)
1 presentation
1 follower

Professor George Bakris

University of Chicago Medicine, Chicago (United States of America)
3 presentations
1 follower

4 more presentations in this session

Welcome and introductions.

Speaker: Professor G. Filippatos (Athens, GR) Professor G. Bakris (Chicago, US)


Cardiovascular protection in patients with chronic kidney disease (CKD) and T2D: time for a new approach?

Speaker: Professor J. Bauersachs (Hannover, DE)


Finerenone in cardiovascular care: exploring a new treatment pathway.

Speaker: Professor A. Voors (Groningen, NL)


Q&A and close.


Access the full session

Cardiorenal benefits of finerenone: protecting the heart and kidneys

Speakers: Doctor P. Taub, Professor G. Bakris, Professor G. Filippatos, Professor G. Bakris, Professor J. Bauersachs...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk